Cigna EVP Koka gets new stock and option grants

Cigna Group executive Durga Prasad Koka reported new equity awards and related tax share withholdings.

Rhea-AI Filing Summary

Cigna Group executive Durga Prasad Koka reported new equity awards and related tax share withholdings. On February 27, 2026, he was granted an employee stock option for 4,127 shares at a price of $0.00 per share, which vests in three equal annual installments beginning March 1, 2027. He also acquired common stock through settlement of strategic performance shares for the 2023–2025 period and through restricted share grants, with vesting for certain restricted shares also starting March 1, 2027. Separate transactions show small blocks of common stock withheld at $287.55 per share to cover tax obligations on these equity awards, rather than open-market sales.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Koka Durga Prasad

Role EVP, Global CIO

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	4,127	$0.00	$0.00
Grant/Award	Common Stock, $.01 Par Value	499	$0.00	$0.00
Grant/Award	Common Stock, $.01 Par Value	2,678	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock, $.01 Par Value	122	$287.55	$35K
Exercise Price or Tax Liability	Common Stock, $.01 Par Value	98	$287.55	$28K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 4,127 contracts (Direct); Common Stock, $.01 Par Value — 7,281 shares (Direct)

Footnotes (5)

1. F1. The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
2. F2. These restricted shares vest in three equal annual installments beginning March 1, 2027.
3. F3. Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
4. F4. Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
5. F5. This option vests in three equal annual installments beginning March 1, 2027.

FAQ

What insider transactions did Cigna (CI) report for Durga Prasad Koka?

Cigna reported equity grants and tax-related withholdings for EVP and Global CIO Durga Prasad Koka. He received an option for 4,127 shares and additional common stock awards, while smaller share amounts were withheld to cover tax obligations tied to these equity settlements.

Were Durga Prasad Koka’s Cigna (CI) transactions open-market buys or sells?

The reported Cigna transactions were equity grants and tax withholdings, not open-market trades. Awards were classified as acquisitions, while Form 4 code “F” dispositions reflected shares withheld to satisfy tax liabilities on performance share settlements and restricted share vesting.

How many Cigna (CI) option shares were granted to Durga Prasad Koka?

Durga Prasad Koka received an employee stock option covering 4,127 Cigna shares. The option was granted at a stated price of $0.00 per share and is scheduled to vest in three equal annual installments beginning March 1, 2027, subject to continued service conditions.

What performance period drove Durga Prasad Koka’s Cigna (CI) share settlement?

The reported common stock includes shares from strategic performance awards for the 2023–2025 period. The number of shares delivered was based on actual results compared with pre-established Cigna performance goals, aligning a portion of his compensation with multi-year company performance.

When do Durga Prasad Koka’s Cigna (CI) restricted shares start vesting?

Cigna disclosed that certain restricted shares granted to Durga Prasad Koka vest over three years. These restricted shares are scheduled to vest in three equal annual installments beginning March 1, 2027, creating a longer-term retention and alignment incentive for the executive.

Why were some Cigna (CI) shares disposed of in Durga Prasad Koka’s Form 4?

The Form 4 shows share dispositions strictly for tax withholding purposes. Cigna reported that specific common shares were withheld to satisfy tax obligations arising from settlement of strategic performance shares and from vesting of restricted stock awards, not discretionary share sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 07:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koka Durga Prasad

(Last) (First) (Middle)

900 COTTAGE GROVE RD

(Street)

BLOOMFIELD CT 06002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global CIO

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	02/27/2026		A		499(1)	A	$0	4,823	D
Common Stock, $.01 Par Value	02/27/2026		A		2,678(2)	A	$0	7,501	D
Common Stock, $.01 Par Value	02/27/2026		F		122(3)	D	$287.55	7,379	D
Common Stock, $.01 Par Value	02/27/2026		F		98(4)	D	$287.55	7,281	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$287.5475	02/27/2026		A		4,127		03/01/2027(5)	02/27/2036	Common Stock, $.01 Par Value	4,127	$0	4,127	D

Explanation of Responses:

1. The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

2. These restricted shares vest in three equal annual installments beginning March 1, 2027.

3. Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

4. Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

5. This option vests in three equal annual installments beginning March 1, 2027.

Remarks:

	Tyler Gratton, attorney-in-fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.